Sign in
JBIO Stock Price, Chart, Stats & News
Jade Biosciences, Inc.
Save
Jade Biosciences, Inc. (JBIO) is a dividend-paying stock. It distributes annually.
JBIO chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -0.06% |
ROA | -36.43% |
ROE | -64.64% |
D/E | 0.00x |
Interest coverage ratio | – |
JBIO valuation
P/E | – |
P/S | – |
P/B | 2.85x |
P/CF | -9.17x |
P/FCF | -4.22x |
P/OCF | -9.17x |
PEG | -0.14x |
EV multiple | -5.54x |
About
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage.
Related lists
Similar securities
Based on sector and market capitalization
Report issue